Mohini Health & Hygiene Q2 Results 2026 (FY27) statement: Revenue & Margins
Q2 FY27 results statement: what the company reported on revenue, margins and capex.
Top 10 Healthcare Equipment & Supplies companies on management guidance
See the sector's top 10 — free with your mobile number.
Based on Mohini Health & Hygiene Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.
The short version
Revenue from operations for the half year ended 30th Sept 2026 is ₹11,043.00 lakhs, compared to ₹7,353.87 lakhs for the half year ended 30th Sept 2025, showing a significant increase year-on-year. The results statement reports the following for the quarter ended 30th September 2026:.
From Mohini Health & Hygiene Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.
How did Mohini Health & Hygiene's revenue grow in the September 2026 quarter?
- Revenue from operations for the half year ended 30th Sept 2026 is ₹11,043.00 lakhs, compared to ₹7,353.87 lakhs for the half year ended 30th Sept 2025, showing a significant increase year-on-year.
- Total income for half year ended 30th Sept 2026 is ₹12,179.84 lakhs against ₹7,610.71 lakhs in the same period last year.
- The Board deferred the proposal for raising funds by way of a Rights Issue and approved a proposal for investment/acquisition through subsidiary, indicating strategic expansion but without specific revenue or volume forecasts.
What happened to Mohini Health & Hygiene's margins in Q2 FY27?
The investor presentation reports the following for the quarter ended 30th September 2026:
Locked: what Mohini Health & Hygiene Ltd said on margins
Also locked on this page: fundraising, order book
Free account, 30 seconds. No card needed.
What capex is Mohini Health & Hygiene planning?
- Acquisition of Alpine Developers and Promotors (Partnership Firm) by Dhananya Capital Private Limited (subsidiary of Mohini Health & Hygiene Ltd).
- Consideration: Rs. 12 crore (cash).
- Stake acquisition: 99% by Dhananya Capital Pvt Ltd; 1% held by Mr. Vipan Kumar.
- Business: Real estate development (new business area outside main manufacturing).
- No operational turnover in last 3 years; net worth Rs. 63.62 lakhs as of March 31, 2026.
- Purpose: Diversification, exploring new business opportunities, potential synergies.
- Governmental/regulatory approvals: Not required.
2 more points from Mohini Health & Hygiene Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Equipment & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Mohini Health & Hygiene raising money or cutting debt?
The Board deferred the proposal for raising funds by way of a Rights Issue; this will be considered at a…
Locked: what Mohini Health & Hygiene Ltd said on fundraising
Also locked on this page: margins, order book
Free account, 30 seconds. No card needed.
How big is Mohini Health & Hygiene's order book?
See what Mohini Health & Hygiene Ltd said on order book & pipeline — free account, 30 seconds.
More Q2 FY27 results in Healthcare Equipment & Supplies
- Molbio Diagnosti Q2 FY27 results
- Poly Medicure Q2 FY27 results
- Sahajanand Medi Q2 FY27 results
- Fischer Medical Q2 FY27 results
- Tarsons Products Q2 FY27 results
- Laxmi Dental Q2 FY27 results
- Vasa Denticity Q2 FY27 results
- OSEL Devices Q2 FY27 results
All Q2 FY27 results | Healthcare Equipment & Supplies rankings
Continue your research
Others in Healthcare Equipment & Supplies this season
- Fischer Medical (Q2 FY27)
For the quarter ended September 30, 2026, the Standalone revenue from operations was ₹27.62 Lakhs compared to ₹742.69 Lakhs in Q2 FY 2025, showing a…
- Aprameya Enginee (Q2 FY27)
216.21 lakhs, up 97% year-on-year (YoY). Key results statement takeaways from Aprameya Engineering Ltd's Q2 FY27 results statement — and how it ranks against se
- QMS Medical (Q2 FY27)
4,470.00 lakhs in Q2 2025), a year-on-year increase of approximately 17.5% . Key results statement takeaways from QMS Medical Allied Services Ltd's Q2 FY27 resu
- OSEL Devices (Q2 FY27)
31.8% increase ((19,363.37 . Key results statement takeaways from OSEL Devices Ltd's Q2 FY27 results statement — and how it ranks against sector peers.
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Equipment & Supplies
on management's own guidance
- Strong growth2
- Strong growth1
- Poly MedicureGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Mohini Health & Hygiene Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Mohini Health & Hygiene Ltd Q2 FY27 results?
Revenue from operations for the half year ended 30th Sept 2026 is ₹11,043.00 lakhs, compared to ₹7,353.87 lakhs for the half year ended 30th Sept 2025, showing a significant increase year-on-year. The results statement reports the following for the quarter ended 30th September 2026:.
What is Mohini Health & Hygiene Ltd share price analysis?
Mohini Health & Hygiene Ltd currently shows a neutral. The stock trades at a P/E of N/A with a market cap of ₹49 Cr. Investors should review the full earnings analysis for detailed insights.
Is Mohini Health & Hygiene Ltd planning capital expenditure?
Acquisition of Alpine Developers and Promotors (Partnership Firm) by Dhananya Capital Private Limited (subsidiary of Mohini Health & Hygiene Ltd).
Keep Mohini Health & Hygiene Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
